All In MedTech

Device Trial Radar · NCT06691750

Clinical Impact of Uterine Repair During Cesarean Section With Barbed Suture on the Incidence of Isthmocele

Clinical Impact of Uterine Repair During Cesarean Section With Barbed Suture on the Incidence of Isthmocele and Its Ultrasound and Molecular Characteristics: a Randomized Controlled Trial

Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 420 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

420

Planned (sponsor's estimate)

Start

Nov 22, 2024

Primary completion

Dec 2027

Study completion May 2028

Sponsor

Lead sponsor
Hospital Clinic of BarcelonaAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 15, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Prevention
FDA-regulated device
No
Who can join
Female only, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Pregnant women, irrespective of their pregnancy risk, who undergo a cesarean section for any reason will be randomized to one of two suturing techniques: conventional suture or barbed suture for uterine repair after the cesarean section. Following surgery, these patients will be followed up for clinical outcomes, ultrasound evaluation of the uterine scar, and study of the hypoxic-inflammatory environment of the uterine cavity.

Conditions

  • Isthmocele
  • Cesarean Scar Defect
  • Pelvic Pain
  • Spotting
  • Infertility
  • Uterine Niche
  • Uterine Abnormal Bleeding
  • Niche

Interventions

  • Barbed sutureDevice

    Size 0 barbed absorbable monofilament suture with unidirectional spikes that includes a loop in one of its ends, not requiring knots.

  • Conventional smooth sutureDevice

    Size 1 smooth multifilament absorbable polyglactin suture.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Rate of IsthmoceleTime frame: Nine to twelve months after cesarean section.
  2. Ultrasonographic Measurements of IsthmoceleTime frame: Nine to twelve months after cesarean section.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Hospital Clínic de Barcelona

    Barcelona, Spain · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.